Summary
The variability and predictability of the plasma concentration of ampicillin and kanamycin in new-born infants being treated for infections are discussed. For kanamycin a standard dose regimen of 7.5 mg/kg/12 h is recommended.
Similar content being viewed by others
References
Driessen, O. M. J., Sorgedrager, N., Michel, M. F., Kerrebijn, K. F., Hermans, J.: Pharmacokinetic aspects of therapy with ampicillin and kanamycin in new-born infants. Europ. J. clin. Pharmacol.13, 449–457 (1978)
Gladtke, E., Van Hattingberg, H. M.: Pharmacokinetik. Eine Einführung. Berlin, Heidelberg, New York: Springer 1973
Huber, J. P., Nelson, J. D.: Re-evaluation of kanamycin dosage in infants and children. Antimicrob. Agents Chemother.9, 899–902 (1976)
Howard, J. B., McCracken, G. H.: Reappraisal of kanamycin usage in neonates. J. Pediatr.86, 949–956 (1975)
Simon, H., Axline, S.: Clinical pharmacology of kanamycin in premature infants. Ann. N. Y. Acad. Sci.132, 1020–1025 (1966)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Driessen, O.M.J., Sorgedrager, N., Michel, M.F. et al. Variability and predictability of the plasma concentration of ampicillin and kanamycin in new-born infants. Eur J Clin Pharmacol 15, 133–137 (1979). https://doi.org/10.1007/BF00609877
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00609877